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Purpose: The aim of this study was to evaluate the accuracy of ORange® Gen II (WaveTec 
Vision, Aliso Viejo, CA).
Setting: The Surgical Suites, Honolulu, HI.
Methods: The prospective 28 consecutive cataract surgical cases were selected from 85 cataract 
surgical cases between December 16, 2010 and February 24, 2011. With the same intraocular 
lens implantation, the predicted spherical equivalent refraction from IOLMaster® (Carl Zeiss 
AG, Oberkochen, Germany) and ORange Gen II were statistically compared and verified with 
1-month postoperative manifest refraction. The data were put into IBM SPSS 19 (SPSS Inc, 
Chicago, IL) for analysis of variance. Pearson’s correlation coefficient was also calculated to 
evaluate the correlation between the IOLMaster, ORange Gen II, and 1-month postoperative 
manifest refraction.
Results: There were no statistically significant differences in the mean spherical equivalent 
refraction from the IOLMaster, ORange Gen II, and 1-month postoperative manifest refraction 
(IOLMaster −0.40 diopters, P = 0.07; ORange Gen II −0.43 diopters, P = 0.16; 1-month refraction 
−0.41 diopters, P = 0.07). Pearson’s correlation study demonstrated that all three were positively 
correlated (P , 0.05), with the strongest correlation between the ORange Gen II and 1-month 
postoperative manifest refraction (r = +0.6, P , 0.01).
Conclusion: The ORange Gen II can be considered as an alternative method for intraocular 
lens selection for cataract patients.
Keywords: cataract surgery, phacoemulsification, IOL implantation, IOLMaster®, ORange® 
Gen II, postoperative refraction
Introduction
The intraoperative wavefront aberrometer (ORange®; WaveTec Vision, Aliso Viejo, 
CA) incorporates a Talbot–Moiré interferometer to enable cataract surgeons to perform 
refraction during cataract surgery. The Talbot–Moiré interferometer is different from 
other wavefront technologies, such as Hartmann–Shack, in that it uses optical and 
mathematical principles to capture and analyze a wavefront. The wavefront passes 
through a pair of gratings set at a specific distance and angle offset to each other. The 
diffraction of the wavefront as it passes through the grating pair produces a fringe 
pattern. Aberrations cause distortions in the fringe pattern and, after being analyzed, 
are translated into the refractive value.1 Cataract surgeons can confirm or change the 
intraocular lens (IOL) based on the output of the ORange intraoperatively. Currently, 
the IOLMaster® (Carl Zeiss AG, Oberkochen, Germany) is the widely accepted 
equipment used to select the proper IOL power for patients before cataract surgery 
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(data from Carl Zeiss). However, if the cataract is dense 
or mature, the IOLMaster is unable to perform an accurate 
selection. In this case, the ORange Gen ll can be used 
intraoperatively to conduct the selection of the IOL after a 
dense cataract has been removed.
The ORange Gen I can perform intraoperative refraction 
after IOL implantation (pseudophakic) while Gen II can 
perform refraction before IOL implantation (aphakic).2,3 
The issue with ORange Gen I is that the surgeon must 
exchange the IOL if the refraction output from the ORange 
Gen I is   different from the proposed refraction. The ORange 
Gen I is the first generation of ORange which is an   objective 
pseudophakic refractor and an intraoperative wavefront 
aberrometer.
Many limitations apply in using the ORange Gen II, such 
as small pupil, corneal disease, fovea disease, wound   leakage, 
nystagmus, local block, and use of lidocaine gel. There are 
also differences in performing the refraction between the 
ORange Gen II and postoperative manifest refraction, such 
as patient position, corneal edema, and pupil size.
A search of the peer-reviewed literature to date produced 
no comparative studies of the ORange Gen II and IOL-
Master for the accuracy of IOL power selection. However, 
there were several studies sponsored by the manufacturer 
(WaveTec Vision) that demonstrated better refractive 
outcomes after using the ORange.2,3 Since the IOLMaster 
is the widely accepted equipment used to select the proper 
IOL power for patients, this study compared the prediction 
of refractive outcomes between the ORange Gen II and the 
IOLMaster with the same IOL implantation to the manifest 
refractive outcomes 1 month after uncomplicated cataract 
surgery.
Methods
The prospective 28 consecutive cataract surgical cases were 
randomly selected from 85 cataract surgical cases between 
December 16, 2010 and February 24, 2011 at The Surgical 
Suites, Honolulu, HI. Subjects received a sequentially 
numbered sealed envelope containing the randomization 
assignment to be in the ORange Gen II study. Sixteen males 
and twelve females were selected into the study with an 
age range of 56–80 years old. One surgeon performed all 
the cases. All patients’ eyes were under topical anesthesia. 
There were no complications in any of the 28 cases and no 
case withdrawals. Patients who were cooperative for the 
measurements without squeezing the eyes were included. 
During the measurement, the speculum was carefully checked 
to make sure it was not tight on the eyelid. Exclusion criteria 
included subjects with a small pupil, corneal disease, fovea 
disease, leaking wound, and nystagmus, which may prevent 
their eyes from being measured by the equipment. The 
IOLMaster was used to select the appropriate power of IOL 
for implantation by the surgeon. The predicted postoperative 
spherical equivalent (SE) refractions from the IOLMaster 
were recorded. Since only the SE was used in the IOLMaster 
as the refractive data, the vector of cylinder power was not 
compared. After phacoemulsification, the ORange Gen II was 
used by the surgeon. There were several IOLs of different 
power with different predicted postoperative refraction shown 
on the ORange panel after the output reading. The IOLs 
Table 1 Summary of statistics
Master Orange Refraction
Mean spherical equivalent 
refraction (diopters)
−0.40 −0.43 −0.41
n 28 28 28
Standard deviation 0.30 0.34 0.39
Abbreviations: Master, IOLMaster®; Orange, ORange® Gen II; Refraction, 1-month 
postoperative manifest refraction.
Table 2 Test of homogeneity of the variance for the validity of 
analysis of variance
Levene’s test statistic df1 df2 P
Master 2.067 7 17 0.105
Orange 3.351 7 17 0.020
Note: P value is not significant (P . 0.05) implying that the groups are homogeneous/
have equal variance. Therefore, the analysis of variance is valid.
Abbreviations: df, degrees of freedom; Master, IOLMaster®; Orange, ORange® Gen II.
Table  3  Analysis  of  variance  of  mean  spherical  equivalent 
refractions
Sum of  
squares
df Mean 
square
F P
Master
  Between groups 1.592 12 0.133 2.248 0.070
  Within groups 0.885 15 0.059
  Total 2.478 27
Orange
  Between groups 1.834 12 0.153 1.721 0.159
  Within groups 1.332 15 0.089
  Total 3.167 27
Refraction
  Between groups 2.632 12 0.219 2.257 0.069
  Within groups 1.458 15 0.097
  Total 4.090 27
Note:  All  P  values  were  greater  than  0.05,  which  shows  that  all  three  mean 
refractions had no statistically significant differences at the 5% level.
Abbreviations: df, degrees of freedom; F, one way analysis of variance; Master, IOLMaster®; 
Orange, ORange® Gen II; Refraction, 1-month postoperative manifest refraction.
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Figure 1 Plot of means. 
Note: The error bars (corresponding to 95% confidence intervals for the means) 
with a reference line for the overall group mean (−0.4) show that all three mean 
refractions were similar.
Abbreviations: CI, confidence interval; master, IOLMaster®; Orange, ORange® 
Gen II; refraction, 1-month postoperative manifest refraction.
with the same power that the IOLMaster selected were used 
and the predicted postoperative SE refraction was recorded. 
One month later, the patients were examined for a manifest 
refraction by the technician and the SE refraction data were 
recorded. The technician was masked (blinded) by being given 
a numbered form (excluding record of the subject’s name, 
IOL type, and other information) to record the refraction. The 
data were then entered into IBM SPSS version 19.0.1 (SPSS 
Inc, Chicago, IL) for analysis of variance comparing the mean 
predicted SE refraction from the IOLMaster, ORange Gen 
II, and 1-month manifest refraction.
Results
There were no statistically significant differences (P . 0.05) 
in the mean SE refraction from the IOLMaster, ORange 
Gen II, and 1-month postoperative manifest refraction 
(IOL  Master −0.40 diopters [D], P = 0.07; ORange Gen 
II −0.43 D, P = 0.16; 1-month postoperative manifest 
refraction −0.41 D, P = 0.07) (Tables 1–3, Figure 1). The 
surgeon preferred postoperative target refraction around 
−0.50 D instead of plano. Pearson’s correlation study 
demonstrated that all three were positively correlated in 
the prediction of postoperative refraction (P , 0.05), with 
the strongest   correlation between the ORange Gen II and 
1-month   postoperative refraction (r = +0.6, P , 0.01). The 
second strongest correlation was between the IOLMaster and 
ORange Gen II (r = +0.5, P , 0.01) and the weakest correla-
tion was between the IOL Master and 1-month postopera-
tive manifest refraction (r = +0.44, P , 0.05) (Tables 4–6, 
Figures 2–4).
Discussion
The present work is a subsequent study of the accuracy 
and reliability of the intraoperative wavefront aberrometer, 
ORange Gen II. The ORange Gen I can measure the real-
time refraction after IOL implantation (pseudophakic), 
while Gen II can perform refraction before IOL implantation 
(aphakic)1,2 and verify the power of the intended IOL before 
implantation to avoid IOL exchange. The first study evaluated 
ORange Gen I and found that it can be a good reference intra-
operatively for difficult cases such as outliers from previous 
refractive surgery or cornea abnormality.3
This is the first study to evaluate ORange Gen II in 
predicting postcataract surgery refraction by comparing it 
with IOLMaster prediction and 1-month postoperative mani-
fested refraction. In this study, the involvement of a single 
surgeon, a single surgical center, a single technician, and 
Table  4  Correlation  between  the  predicted  refraction  from 
IOLMaster® and ORange® Gen II
Master Orange
Pearson’s correlation 1 0.481*
Significance (two-tailed) 0.010
n 28 28
Note: *Correlation is significant at the 0.01 level (two-tailed), r = +0.5.
Abbreviations: Master, IOLMaster®; Orange, ORange® Gen II; Refraction, 1-month 
postoperative manifest refraction.
Table  5  Correlation  between  the  predicted  refraction  from 
IOLMaster® and 1-month postoperative manifest refraction
Master Refraction
Pearson’s correlation 1 0.444*
Significance (two-tailed) 0.018
n 28 28
Note: *Correlation is significant at the 0.05 level (two-tailed) r = +0.44.
Abbreviations: Master, IOLMaster®; Refraction, 1-month postoperative manifest 
refraction.
Table  6  Correlation  between  the  predicted  refraction  from 
ORange® Gen II and 1-month postoperative manifest refraction
Refraction Orange
Pearson’s correlation 1 0.586*
Significance (two-tailed) 0.001
n 28 28
Note: *Correlation is significant at the 0.01 level (two-tailed) r = +0.6.
Abbreviations: Orange, ORange® Gen II; Refraction, 1-month postoperative manifest 
refraction.
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single equipment was used to avoid interrater disagreement. 
Analysis of variance is valid for this data and is a valid 
procedure to use since the P value was not significant 
(P . 0.05), implying that the groups are homogeneous, ie, 
have equal variance. There were no statistically significant 
differences in the prediction of mean refraction from the 
IOLMaster, ORange Gen II, and 1-month postoperative 
manifest refraction. However, because the power calculation 
indicated insufficient subjects for this study, Pearson’s 
correlation coefficient was calculated for comparison. The 
strongest correlation was between the predicted refraction 
by ORange and 1-month postoperative manifest refraction. 
Despite there being no statistically significant differences 
in the mean SE, correlation between the three predicted 
refractive outcomes was not excellent. This may be due to 
many different situations intraoperatively that can affect 
the measurement, such as intraocular pressure, IOL posi-
tion, and IOL power. Clinically, the IOLMaster may not be 
able to obtain a reading from mature cataracts; the ORange 
Gen II can be used after the mature cataract is removed to 
obtain a reading.
Conclusion
The ORange Gen II predicted equivalent and slightly better 
refractive outcomes compared to the IOLMaster in patients 
undergoing routine cataract surgery. The ORange Gen II can 
be considered as an alternative method for determining IOL 
selection for these patients.
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